iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) was the recipient of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 1,420,000 shares, a decrease of 6.0% from the June 30th total of 1,510,000 shares. Based on an average daily trading volume, of 284,300 […]
Endurant Capital Management LP bought a new stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 21,041 shares of the company’s stock, valued at approximately $411,000. Endurant Capital Management LP owned […]
Endurant Capital Management LP acquired a new position in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 21,041 shares of the company’s stock, valued at approximately $411,000. Other hedge funds also recently made changes to their positions in the company. American International Group Inc. raised its […]
Tang Capital Management LLC trimmed its position in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) by 76.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 216,700 shares of the company’s stock after selling 720,800 shares during the […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,780,000 shares, an increase of 6.6% from the April 30th total of 1,670,000 shares. Approximately 6.1% of the company’s stock are sold short. Based […]